NCT05097417

Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer

A Prospective Open-Label Randomized Study of Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: Shanghai 10th People's Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Lung cancer is the leading cause of cancer related mortality. At present, surgical treatment is the main choice for early-stage lung cancer. Even after surgery, the 5-year recurrence rate is still as high as 18.4%-24%. Traditional Chinese medicine combined with thermal and cold ablation could be an alternative treatment. Small sample clinical cases verified that this therapy could be an efficacy and safe treatment in a short period. The primary aim of this trial is to evaluate the efficacy of traditional Chinese medicine combined with thermal and cold ablation for patients with stage I non-small cell lung cancer.

Conditions

• Non-small Cell Lung Cancer Stage I

Interventions

Type	Name	Description
COMBINATION_PRODUCT	traditional Chinese medicine and ablation in the primary tumor sites	Patients will be treated with traditional Chinese medicine and ablation in the primary tumor sites
PROCEDURE	ablation	Patients will be treated with ablation in the primary tumor sites

Timeline

• Start date: 2021-11-01
• Primary completion: 2023-11-01
• Completion: 2024-11-01
• First posted: 2021-10-28
• Last updated: 2021-10-28

Locations

1 site across 1 country: China